WHO's Historic Approval of Malaria Drug for Infants Brings New Hope
The World Health Organization has approved the first malaria drug specifically for infants, a significant step toward protecting vulnerable children under five who are at high risk of malaria.
On April 24, 2026, the World Health Organization announced the approval of the first malaria drug designed for infants, marking a pivotal moment in the fight against the disease.
This new medication targets children under five, who represent a staggering two-thirds of malaria-related deaths globally, highlighting the urgent need for effective treatments in this age group.
Health experts anticipate that this drug could lead to a substantial decrease in malaria fatalities among young children, offering renewed hope for families and communities affected by the disease.